PhRMA has sued the state of Minnesota to block implementation of the Alec Smith Insulin Affordability Act, a law that requires manufacturers to provide insulin free to thousands of state residents. If allowed to stand,...

Sen. Chuck Grassley (R-Iowa) Monday accused Democrats of “walking away from” drug pricing legislation, while Sen. Ron Wyden (D-Ore.) refuted the allegation, saying that Democrats hadn’t walked away because “Republicans never showed up in the...

A coalition of global health organizations led by the WHO Friday publicly released plans for a global COVID-19 vaccine purchasing pool that is intended to ensure that priority populations around the world have access to...

By requesting that the Supreme Court invalidate the entire Affordable Care Act, the Trump administration has put into play the biosimilars pathway and other parts of the law that are unrelated to core healthcare coverage...

Despite the high-profile nature of the patent dispute between Illumina and Chinese competitor BGI Genomics, two of the largest players in next-generation sequencing, there is no reason to believe it will become embroiled in the...

NHS England is calling for biopharmas to apply for a contract to supply an antibiotic via the U.K.’s pilot subscription program, which will pay manufacturers a flat annual rate over 10 years for access to...

President Donald Trump’s decision to bar most employment-based visas through year-end could have a broad impact on the U.S. biopharma industry, which is heavily dependent on temporary and permanent immigrants to fill jobs from junior...

With three months left until Congress’ deadline to reauthorize the rare pediatric disease Priority Review voucher program, two senators introduced legislation late last week to make the program permanent. FDA awards a voucher upon the...

Biopharmaceutical companies and academic scientists around the world have set aside commercial and professional rivalries to collaborate on the development of vaccines to protect against COVID-19. Technologies that have been slowly advancing for a decade...

A trio of Democrats on the House Oversight Committee are asking FDA for more information on how the agency plans to evaluate and deploy COVID-19 vaccines, in an effort to ensure the process is transparent,...

Editor’s Note: BioCentury’s co-founders, Chairman Karen Bernstein, Ph.D., and President & CEO David Flores, have written to the company’s employees about BioCentury’s response to racism and racial inequities in healthcare. It is published in its...

In response to a court decision overturning mandatory disclosures of drug pricing in television ads, Sens. Chuck Grassley and Dick Durbin are pushing legislation that would achieve similar goals. On Tuesday, the U.S. Court of...

The Access to COVID-19 Tools Accelerator plans to make advance purchase commitments for more than 15 billion doses of COVID-19 vaccines over six years, starting with 1.1 billion in 2021. The accelerator is a collaboration...

The push to secure supplies of COVID-19 vaccines gathered more steam Wednesday with the European Commission launching an EU-wide procurement strategy to ensure equitable access to COVID-19 vaccines in Europe. The initiative is separate from...

Panic buying of vaccines by high income countries, mopping up supply and squeezing out lower income countries, is the nightmare postscript to COVID-19 that international health agencies envisage could play out if steps aren’t taken...